Robotically Assisted Surgical Devices are being used at an increased rate in operating rooms for minimally invasive surgeries. They are said to reduce scarring, bleeding, infection and recovery time. According to an article in NBC News, these devices may be linked to a decrease in long-term survival for cancer-related surgery, specifically for breast and cervical cancer. The FDA warns that there is a lack of evidence regarding the benefits of robotically assisted surgery for any cancer related surgery and that devices have been used for uses not granted by market authorization by the FDA. As Doctors and patients decide which procedures to use robotic assistance, they should be aware of the lack of evidence regarding the safety and effectiveness of this form of cancer treatment so they can make the best clinical and personal decision.
Robotically Assisted Surgery Risky for Certain Cancer-Related Procedures
As we enter the recovery phase from the COVID-19 pandemic, hospitals and healthcare systems must develop immediate, near and long-term strategies to best position themselves for success. Our expertise makes us the perfect partner as you plan for and manage near and long-term goals in the post-COVID OR. We will use our over 20 years of experience working collaboratively with hospitals and anesthesia groups of all sizes adapt their surgical platform in response to the COVID-19 pandemic and create plans for reopening the OR and managing backlogged surgical cases.
During this time of uncertainty, we are here to assist your Operating Room leadership and Governance teams in any way we can.